Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 Study of ASP1585 (Bixalomer) in Hemodialysis Patients with Hyperphosphatemia
NCT00505037Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Oct 2007
- Primary completion
- Sep 2008
- Modality
- Polymer-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bixalomer in hyperphosphatemia, sponsored by Astellas Pharma. Started Oct 2007; status: completed.
02
Drugs
bixalomer
03
Conditions
hyperphosphatemia
Beyond the preview
Go deeper on NCT00505037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505037.